These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 9279451)
1. Cross-sectional and longitudinal changes in total and high-density-lipoprotein cholesterol levels over a 20-year period in elderly men: the Honolulu Heart Program. Abbott RD; Sharp DS; Burchfiel CM; Curb JD; Rodriguez BL; Hakim AA; Yano K Ann Epidemiol; 1997 Aug; 7(6):417-24. PubMed ID: 9279451 [TBL] [Abstract][Full Text] [Related]
2. Changes in total and high-density lipoprotein cholesterol over 10- and 20-year periods (the Honolulu Heart Program). Abbott RD; Yano K; Hakim AA; Burchfiel CM; Sharp DS; Rodriguez BL; Curb JD Am J Cardiol; 1998 Jul; 82(2):172-8. PubMed ID: 9678287 [TBL] [Abstract][Full Text] [Related]
3. Association of insulin levels with lipids and lipoproteins in elderly Japanese-American men. Burchfiel CM; Abbott RD; Curb JD; Sharp DS; Rodriguez BL; Arakaki R; Yano K Ann Epidemiol; 1998 Feb; 8(2):92-8. PubMed ID: 9491933 [TBL] [Abstract][Full Text] [Related]
4. Screening for coronary heart disease in elderly men based on current and past cholesterol levels. Hakim AA; Curb JD; Burchfiel CM; Rodriguez BL; Sharp DS; Yano K; Abbott RD J Clin Epidemiol; 1999 Dec; 52(12):1257-65. PubMed ID: 10580790 [TBL] [Abstract][Full Text] [Related]
5. High density lipoprotein cholesterol and the risk of stroke in elderly men: the Honolulu heart program. Curb JD; Abbott RD; Rodriguez BL; Masaki KH; Chen R; Popper JS; Petrovitch H; Ross GW; Schatz IJ; Belleau GC; Yano K Am J Epidemiol; 2004 Jul; 160(2):150-7. PubMed ID: 15234936 [TBL] [Abstract][Full Text] [Related]
6. Lipid and lipoprotein predictors of coronary heart disease in elderly men in the Honolulu Heart Program. Reed D; Benfante R Ann Epidemiol; 1992; 2(1-2):29-34. PubMed ID: 1342261 [TBL] [Abstract][Full Text] [Related]
7. Lipoprotein lipids in older people. Results from the Cardiovascular Health Study. The CHS Collaborative Research Group. Ettinger WH; Wahl PW; Kuller LH; Bush TL; Tracy RP; Manolio TA; Borhani NO; Wong ND; O'Leary DH Circulation; 1992 Sep; 86(3):858-69. PubMed ID: 1516198 [TBL] [Abstract][Full Text] [Related]
8. Lipids and lipoproteins as predictors of coronary heart disease, stroke, and cancer in the Honolulu Heart Program. Reed D; Yano K; Kagan A Am J Med; 1986 May; 80(5):871-8. PubMed ID: 3706375 [TBL] [Abstract][Full Text] [Related]
9. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN. J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296 [TBL] [Abstract][Full Text] [Related]
10. Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. Wilson PW; Anderson KM; Harris T; Kannel WB; Castelli WP J Gerontol; 1994 Nov; 49(6):M252-7. PubMed ID: 7963277 [TBL] [Abstract][Full Text] [Related]
12. Distribution of lipid phenotypes in community-living men with coronary heart disease. High prevalence of isolated low levels of high-density lipoprotein cholesterol. Rubins HB; Schectman G; Wilt TJ; Iwane MK Arch Intern Med; 1992 Dec; 152(12):2412-6. PubMed ID: 1456850 [TBL] [Abstract][Full Text] [Related]
13. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group. Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012 [TBL] [Abstract][Full Text] [Related]
14. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910 [TBL] [Abstract][Full Text] [Related]
15. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group. Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751 [TBL] [Abstract][Full Text] [Related]
16. Associations of adiposity with prevalent coronary heart disease among elderly men: the Honolulu Heart Program. Huang B; Rodreiguez BL; Burchfiel CM; Chyou PH; Curb JD; Sharp DS Int J Obes Relat Metab Disord; 1997 May; 21(5):340-8. PubMed ID: 9152734 [TBL] [Abstract][Full Text] [Related]
17. Lipids and lipoproteins in symptomatic coronary heart disease. Distribution, intercorrelations, and significance for risk classification in 6,700 men and 1,500 women. The Bezafibrate Infarction Prevention (BIP) Study Group, Israel. Circulation; 1992 Sep; 86(3):839-48. PubMed ID: 1516196 [TBL] [Abstract][Full Text] [Related]
18. Effects of walking on coronary heart disease in elderly men: the Honolulu Heart Program. Hakim AA; Curb JD; Petrovitch H; Rodriguez BL; Yano K; Ross GW; White LR; Abbott RD Circulation; 1999 Jul; 100(1):9-13. PubMed ID: 10393674 [TBL] [Abstract][Full Text] [Related]
19. Distribution and correlates of lipids and lipoproteins in elderly Japanese-American men. The Honolulu Heart Program. Burchfiel CM; Abbott RD; Sharp DS; Curb JD; Rodriguez BL; Yano K Arterioscler Thromb Vasc Biol; 1996 Nov; 16(11):1356-64. PubMed ID: 8911274 [TBL] [Abstract][Full Text] [Related]
20. Primary Low Level of High-Density Lipoprotein Cholesterol and Risks of Coronary Heart Disease, Cardiovascular Disease, and Death: Results From the Multi-Ethnic Study of Atherosclerosis. Ahmed HM; Miller M; Nasir K; McEvoy JW; Herrington D; Blumenthal RS; Blaha MJ Am J Epidemiol; 2016 May; 183(10):875-83. PubMed ID: 27189327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]